Vimab Group AB (publ) (STO:VIMAB)
2.880
+0.080 (2.86%)
At close: Mar 20, 2026
Revenue by Segment
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence.